These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 27337847)

  • 61. Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.
    Fujita K; Yamada H; Iijima M; Ichida K
    PLoS One; 2019; 14(12):e0226918. PubMed ID: 31891613
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyperuricemia, gout, and cardiovascular disease: an update.
    Abeles AM
    Curr Rheumatol Rep; 2015 Mar; 17(3):13. PubMed ID: 25740704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Gout].
    Carey Berner I; Dudler J
    Rev Med Suisse; 2006 Jan; 2(48):160-2. PubMed ID: 16463802
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.
    Perez-Ruiz F; Becker MA
    Curr Med Res Opin; 2015; 31 Suppl 2():9-14. PubMed ID: 26414731
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update on gout 2012.
    So A; Busso N
    Joint Bone Spine; 2012 Dec; 79(6):539-43. PubMed ID: 23165182
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gout in 2006: the perfect storm.
    Terkeltaub R
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 69. Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study.
    Semplicini A
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):119-120. PubMed ID: 32207069
    [No Abstract]   [Full Text] [Related]  

  • 70. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
    Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
    Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
    Shah A; Keenan RT
    Curr Rheumatol Rep; 2010 Apr; 12(2):118-24. PubMed ID: 20425020
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hyperuricaemia and gout: state of the art and future perspectives.
    Dalbeth N; So A
    Ann Rheum Dis; 2010 Oct; 69(10):1738-43. PubMed ID: 20858623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperuricaemia and gout: clinical guideline 2003.
    Meyers OL; Cassim B; Mody GM
    S Afr Med J; 2003 Dec; 93(12 Pt 2):961-71. PubMed ID: 14763409
    [No Abstract]   [Full Text] [Related]  

  • 75. Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems.
    Hiramitsu S; Ishiguro Y; Matsuyama H; Yamada K; Kato K; Noba M; Uemura A; Matsubara Y; Yoshida S; Kani A; Tokuda M; Kato H; Hasegawa K; Uchiyama T; Matsubara S; Mori K; Kimura H; Shino K; Kato Y; Ishii J
    Clin Exp Hypertens; 2014; 36(6):433-40. PubMed ID: 24164405
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Investigational drugs for hyperuricemia.
    Shahid H; Singh JA
    Expert Opin Investig Drugs; 2015; 24(8):1013-30. PubMed ID: 26073200
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of hyperuricemia and gout in kidney and cardiovascular disease.
    Edwards NL
    Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S13-6. PubMed ID: 18822470
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Asymptomatic hyperuricemia: perhaps not so benign?
    Neogi T
    J Rheumatol; 2008 May; 35(5):734-7. PubMed ID: 18464314
    [No Abstract]   [Full Text] [Related]  

  • 79. Chronic hyperuricemia, uric acid deposit and cardiovascular risk.
    Grassi D; Ferri L; Desideri G; Di Giosia P; Cheli P; Del Pinto R; Properzi G; Ferri C
    Curr Pharm Des; 2013; 19(13):2432-8. PubMed ID: 23173592
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.